Hmdb loader
Record Information
Version5.0
StatusPredicted
Creation Date2021-08-23 16:38:31 UTC
Update Date2021-09-16 22:46:40 UTC
HMDB IDHMDB0242050
Secondary Accession NumbersNone
Metabolite Identification
Common NameN-Myristoyl Glutamine
DescriptionN-myristoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504 ). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998 ; PMID: 25136293 ; PMID: 28854168 ).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168 ). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153 ). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293 ). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167 ). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168 ). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC19H36N2O4
Average Molecular Weight356.507
Monoisotopic Molecular Weight356.267507647
IUPAC Name4-carbamoyl-2-tetradecanamidobutanoic acid
Traditional Name4-carbamoyl-2-tetradecanamidobutanoic acid
CAS Registry NumberNot Available
SMILES
CCCCCCCCCCCCCC(=O)NC(CCC(N)=O)C(O)=O
InChI Identifier
InChI=1S/C19H36N2O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-18(23)21-16(19(24)25)14-15-17(20)22/h16H,2-15H2,1H3,(H2,20,22)(H,21,23)(H,24,25)
InChI KeyGQCSFCKGCIEEJN-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as glutamine and derivatives. Glutamine and derivatives are compounds containing glutamine or a derivative thereof resulting from reaction of glutamine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentGlutamine and derivatives
Alternative Parents
Substituents
  • Glutamine or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • Fatty amide
  • Fatty acyl
  • Fatty acid
  • N-acyl-amine
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Primary carboxylic acid amide
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Carbonyl group
  • Organonitrogen compound
  • Organooxygen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organic oxygen compound
  • Organic nitrogen compound
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External DescriptorsNot Available
Ontology
Not AvailableNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.17ALOGPS
logP3.67ChemAxon
logS-5.1ALOGPS
pKa (Strongest Acidic)3.94ChemAxon
pKa (Strongest Basic)-1.1ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area109.49 ŲChemAxon
Rotatable Bond Count17ChemAxon
Refractivity97.79 m³·mol⁻¹ChemAxon
Polarizability42.83 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+192.56930932474
DeepCCS[M-H]-190.01930932474
DeepCCS[M-2H]-223.22330932474
DeepCCS[M+Na]+199.31130932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
N-Myristoyl GlutamineCCCCCCCCCCCCCC(=O)NC(CCC(N)=O)C(O)=O3966.4Standard polar33892256
N-Myristoyl GlutamineCCCCCCCCCCCCCC(=O)NC(CCC(N)=O)C(O)=O2758.9Standard non polar33892256
N-Myristoyl GlutamineCCCCCCCCCCCCCC(=O)NC(CCC(N)=O)C(O)=O3053.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
N-Myristoyl Glutamine,2TMS,isomer #1CCCCCCCCCCCCCC(=O)NC(CCC(=O)N[Si](C)(C)C)C(=O)O[Si](C)(C)C3018.1Semi standard non polar33892256
N-Myristoyl Glutamine,2TMS,isomer #1CCCCCCCCCCCCCC(=O)NC(CCC(=O)N[Si](C)(C)C)C(=O)O[Si](C)(C)C2945.9Standard non polar33892256
N-Myristoyl Glutamine,2TMS,isomer #1CCCCCCCCCCCCCC(=O)NC(CCC(=O)N[Si](C)(C)C)C(=O)O[Si](C)(C)C3562.3Standard polar33892256
N-Myristoyl Glutamine,2TMS,isomer #2CCCCCCCCCCCCCC(=O)N(C(CCC(N)=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C2946.3Semi standard non polar33892256
N-Myristoyl Glutamine,2TMS,isomer #2CCCCCCCCCCCCCC(=O)N(C(CCC(N)=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C2837.3Standard non polar33892256
N-Myristoyl Glutamine,2TMS,isomer #2CCCCCCCCCCCCCC(=O)N(C(CCC(N)=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C4167.7Standard polar33892256
N-Myristoyl Glutamine,2TMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C)C(=O)O)[Si](C)(C)C3028.7Semi standard non polar33892256
N-Myristoyl Glutamine,2TMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C)C(=O)O)[Si](C)(C)C2989.2Standard non polar33892256
N-Myristoyl Glutamine,2TMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C)C(=O)O)[Si](C)(C)C3633.9Standard polar33892256
N-Myristoyl Glutamine,2TMS,isomer #4CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O3186.8Semi standard non polar33892256
N-Myristoyl Glutamine,2TMS,isomer #4CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O2997.6Standard non polar33892256
N-Myristoyl Glutamine,2TMS,isomer #4CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O3720.5Standard polar33892256
N-Myristoyl Glutamine,3TMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C3033.8Semi standard non polar33892256
N-Myristoyl Glutamine,3TMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C2982.8Standard non polar33892256
N-Myristoyl Glutamine,3TMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C3251.2Standard polar33892256
N-Myristoyl Glutamine,3TMS,isomer #2CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C3155.6Semi standard non polar33892256
N-Myristoyl Glutamine,3TMS,isomer #2CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C3001.5Standard non polar33892256
N-Myristoyl Glutamine,3TMS,isomer #2CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C3282.4Standard polar33892256
N-Myristoyl Glutamine,3TMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O)[Si](C)(C)C3155.4Semi standard non polar33892256
N-Myristoyl Glutamine,3TMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O)[Si](C)(C)C3043.0Standard non polar33892256
N-Myristoyl Glutamine,3TMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O)[Si](C)(C)C3427.5Standard polar33892256
N-Myristoyl Glutamine,4TMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C3141.7Semi standard non polar33892256
N-Myristoyl Glutamine,4TMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C3048.7Standard non polar33892256
N-Myristoyl Glutamine,4TMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C3078.8Standard polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #1CCCCCCCCCCCCCC(=O)NC(CCC(=O)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3542.8Semi standard non polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #1CCCCCCCCCCCCCC(=O)NC(CCC(=O)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3257.0Standard non polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #1CCCCCCCCCCCCCC(=O)NC(CCC(=O)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3590.5Standard polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #2CCCCCCCCCCCCCC(=O)N(C(CCC(N)=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3449.2Semi standard non polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #2CCCCCCCCCCCCCC(=O)N(C(CCC(N)=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3186.5Standard non polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #2CCCCCCCCCCCCCC(=O)N(C(CCC(N)=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4086.1Standard polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C3549.1Semi standard non polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C3268.2Standard non polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C3667.2Standard polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #4CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O3629.6Semi standard non polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #4CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O3304.1Standard non polar33892256
N-Myristoyl Glutamine,2TBDMS,isomer #4CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O3715.0Standard polar33892256
N-Myristoyl Glutamine,3TBDMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3764.2Semi standard non polar33892256
N-Myristoyl Glutamine,3TBDMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3420.5Standard non polar33892256
N-Myristoyl Glutamine,3TBDMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3498.0Standard polar33892256
N-Myristoyl Glutamine,3TBDMS,isomer #2CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3865.5Semi standard non polar33892256
N-Myristoyl Glutamine,3TBDMS,isomer #2CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3448.4Standard non polar33892256
N-Myristoyl Glutamine,3TBDMS,isomer #2CCCCCCCCCCCCCC(=O)NC(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C3487.9Standard polar33892256
N-Myristoyl Glutamine,3TBDMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C3867.0Semi standard non polar33892256
N-Myristoyl Glutamine,3TBDMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C3466.0Standard non polar33892256
N-Myristoyl Glutamine,3TBDMS,isomer #3CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C3588.8Standard polar33892256
N-Myristoyl Glutamine,4TBDMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4070.4Semi standard non polar33892256
N-Myristoyl Glutamine,4TBDMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3651.4Standard non polar33892256
N-Myristoyl Glutamine,4TBDMS,isomer #1CCCCCCCCCCCCCC(=O)N(C(CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3419.2Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - N-Myristoyl Glutamine GC-MS (Non-derivatized) - 70eV, Positivesplash10-03dl-7794000000-ab0f824bf840148432152021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N-Myristoyl Glutamine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-Myristoyl Glutamine 10V, Positive-QTOFsplash10-0a4i-0309000000-846599ece9189344cad52021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-Myristoyl Glutamine 20V, Positive-QTOFsplash10-001j-1901000000-0b77674fcb0d5696bbe82021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-Myristoyl Glutamine 40V, Positive-QTOFsplash10-0f7k-9600000000-77736d8c1af38042fc672021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-Myristoyl Glutamine 10V, Negative-QTOFsplash10-0a4i-0009000000-7cc56c40d0fc34aacab52021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-Myristoyl Glutamine 20V, Negative-QTOFsplash10-0006-9004000000-63ca3ffcaa9de84e25692021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-Myristoyl Glutamine 40V, Negative-QTOFsplash10-0006-9800000000-d09f08abe804a8a423f52021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID13506281
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound18318649
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Bradshaw HB, Walker JM: The expanding field of cannabimimetic and related lipid mediators. Br J Pharmacol. 2005 Feb;144(4):459-65. doi: 10.1038/sj.bjp.0706093. [PubMed:15655504 ]
  2. Grapov D, Adams SH, Pedersen TL, Garvey WT, Newman JW: Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PLoS One. 2012;7(11):e48852. doi: 10.1371/journal.pone.0048852. Epub 2012 Nov 8. [PubMed:23144998 ]
  3. Raboune S, Stuart JM, Leishman E, Takacs SM, Rhodes B, Basnet A, Jameyfield E, McHugh D, Widlanski T, Bradshaw HB: Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation. Front Cell Neurosci. 2014 Aug 1;8:195. doi: 10.3389/fncel.2014.00195. eCollection 2014. [PubMed:25136293 ]
  4. Cohen LJ, Esterhazy D, Kim SH, Lemetre C, Aguilar RR, Gordon EA, Pickard AJ, Cross JR, Emiliano AB, Han SM, Chu J, Vila-Farres X, Kaplitt J, Rogoz A, Calle PY, Hunter C, Bitok JK, Brady SF: Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature. 2017 Sep 7;549(7670):48-53. doi: 10.1038/nature23874. Epub 2017 Aug 30. [PubMed:28854168 ]
  5. Bradshaw HB, Raboune S, Hollis JL: Opportunistic activation of TRP receptors by endogenous lipids: exploiting lipidomics to understand TRP receptor cellular communication. Life Sci. 2013 Mar 19;92(8-9):404-9. doi: 10.1016/j.lfs.2012.11.008. Epub 2012 Nov 20. [PubMed:23178153 ]
  6. Long JZ, Roche AM, Berdan CA, Louie SM, Roberts AJ, Svensson KJ, Dou FY, Bateman LA, Mina AI, Deng Z, Jedrychowski MP, Lin H, Kamenecka TM, Asara JM, Griffin PR, Banks AS, Nomura DK, Spiegelman BM: Ablation of PM20D1 reveals N-acyl amino acid control of metabolism and nociception. Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6937-E6945. doi: 10.1073/pnas.1803389115. Epub 2018 Jul 2. [PubMed:29967167 ]